Home

What's New

Blog Post | Financial Reform

NYT Points Out Overdraft Fees Still A Problem | Ed Mierzwinski

A major article in today's New York Times, "Overdraft Practices Continue to Gut Bank Accounts and Haunt Customers," points out that while 2010 reforms put in place by the pre-CFPB regulators have helped, there's still work to be done to protect consumers from unfair overdraft practices. While years ago banks used "bounced check" fees to deter what was then seen as a negative behavior, more recently they have encouraged overdrafts by offering "standard overdraft protection" as if it is a feature, not a bug. They've made billions.

> Keep Reading
Report | OSPIRG Foundation | Democracy

Oregon’s Multi-Million Dollar Democracy

It is well-established that Oregon’s elections often attract large donors from both within and outside the state and that this is all permissible through a combination of state and federal court decisions as well as Oregon’s longstanding lack of campaign finance regulation. 

> Keep Reading
Blog Post | Public Health

Is your daily routine toxic? | Anna Low-Beer

Because of a lack of regulation, many cosmetics and personal care products contain potentially toxic ingredients, like formaldehyde and lead acetate. What toxic chemicals might you encounter as you go about your daily routine? 

> Keep Reading

Pages

Media Hit | Health Care

Oregon approves Regence rate increase of 14.7%

Rates increases exceeded four times the rate of inflation last year for more than 400,000 Oregonians with individual, small group and portable insurance plans, according to a report released this week by the OSPIRG Foundation, an affiliate of the Oregon State Public Interest Research Group.

> Keep Reading

Pages

News Release | OSPIRG

Consumer complaints to the Consumer Financial Protection Bureau (CFPB) regarding vehicle loans and leases have increased sharply during the coronavirus pandemic, according to a new report by OSPIRG and Frontier Group. The analysis suggests that consumers in Oregon and across the United States are facing abusive and deceptive practices from the automobile lending industry.  

News Release | OSPIRG

The maker of Humira, the world’s best-selling drug, faces a new legal challenge over alleged anticompetitive tactics. Monday, the U.S. Public Interest Research Group (U.S. PIRG) filed an amicus brief in the 7th Circuit Court of Appeals arguing that AbbVie’s strategies of reverse payment settlements and creating “patent thickets” have delayed the entry of biologically similar generic drugs (biosimilars) onto the market, costing Americans billions of dollars. 

Blog Post

The CDC implemented the eviction freeze on Sept. 4 to reduce the number of people on the streets who could get infected with and spread the COVID-19 virus. Landlords and other groups filed lawsuits attempting to strike down the halt on evictions, so the future of the policy remains uncertain.

Blog Post

The FDA doesn’t have the authority to stop retailers from selling dangerous over-the-counter products such as toxic hand sanitizer. Our safety system is broken, and we need to fix it. 

Blog Post

Here’s a guide to your rights depending on how you pay

Support us

Your tax-deductible donation supports OSPIRG Foundation’s work to educate consumers on the issues that matter, and the powerful interests that are blocking progress.

Learn More

You can also support OSPIRG Foundation’s work through bequests, contributions from life insurance or retirement plans, securities contributions and vehicle donations. 




OSPIRG Foundation is part of The Public Interest Network, which operates and supports organizations committed to a shared vision of a better world and a strategic approach to social change.